Related Experiment Video
Updated: Feb 16, 2026

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
Published on: December 5, 2017
Activating mutations in HER2: neu opportunities and neu challenges
Britta Weigelt1, Jorge S Reis-Filho
1Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.
Abstract:
Twenty-five years after the publication of seminal studies showing that HER2 gene amplification and protein overexpression are oncogenic in breast cancer, Bose and colleagues report on the identification of activating HER2 somatic mutations that, albeit rare, may determine the response of breast cancer cells to anti-HER2 agents. These results herald a new era for the potential use of existing HER2-targeted agents for the treatment of patients with HER2-mutant breast cancer.
Insights
Researchers identified rare HER2 gene mutations in breast cancer. These findings suggest that existing HER2-targeted therapies may effectively treat patients with HER2-mutant breast cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- HER2 (Human Epidermal growth factor Receptor 2) gene amplification and protein overexpression are established drivers of breast cancer.
- Anti-HER2 therapies have significantly improved outcomes for patients with HER2-positive breast cancer.
Purpose of the Study:
- To investigate the role of HER2 somatic mutations in breast cancer.
- To determine if these mutations impact response to anti-HER2 agents.
Main Methods:
- Genomic analysis of breast cancer samples.
- Functional studies to assess the impact of identified mutations.
Main Results:
- Identification of activating HER2 somatic mutations in a subset of breast cancer patients.
- These mutations, although rare, were found to influence sensitivity to anti-HER2 therapies.
Conclusions:
- The study identifies a new class of HER2 alterations in breast cancer.
- These findings open possibilities for utilizing existing HER2-targeted drugs in patients with HER2-mutant breast cancer.
More Related Videos
Related Concept Videos
Point and Frameshift Mutations
Mutations in Microorganisms
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Viral Mutations
Mutation, Gene Flow, and Genetic Drift

